Published in Nucl Med Biol on February 01, 1997
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain (2010) 2.37
Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. J Clin Invest (2006) 2.08
History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology (2009) 2.01
Vesicular monoamine transporter 2: role as a novel target for drug development. AAPS J (2006) 1.78
β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Mov Disord (2012) 1.69
Visualizing pancreatic beta-cell mass with [11C]DTBZ. Nucl Med Biol (2006) 1.67
Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology (2014) 1.59
Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. J Cereb Blood Flow Metab (2012) 1.32
VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease. J Neurochem (2007) 1.15
Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol (2012) 1.14
Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. Brain (2013) 1.12
Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology (2012) 1.04
Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain (2011) 1.02
Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disord (2013) 0.96
Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates. Parkinsonism Relat Disord (2014) 0.89
In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations. Nucl Med Biol (2009) 0.89
Whole body [11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates. Eur J Nucl Med Mol Imaging (2007) 0.87
Gender differences in cholinergic and dopaminergic deficits in Parkinson disease. J Neural Transm (Vienna) (2013) 0.82
Neuroimaging and clinical predictors of fatigue in Parkinson disease. Parkinsonism Relat Disord (2015) 0.82
The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease. Behav Brain Res (2013) 0.81
The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. PLoS One (2012) 0.80
Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET. Radiology (2012) 0.79
Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease. Acad Radiol (2016) 0.78
Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease. Arch Neurol (2012) 0.78
Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease. J Gerontol A Biol Sci Med Sci (2014) 0.78
Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease. Parkinsonism Relat Disord (2013) 0.75
Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science (2001) 3.48
A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol (1984) 3.11
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology (1999) 1.86
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Ann Neurol (2000) 1.73
Gigantic jets between a thundercloud and the ionosphere. Nature (2003) 1.70
Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol (1991) 1.66
Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors. Gastroenterology (1968) 1.58
Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. J Nucl Med (1983) 1.55
Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. J Cereb Blood Flow Metab (1999) 1.49
MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans. Neurology (1987) 1.49
Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab (1991) 1.40
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol (1996) 1.35
Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore Epidemiologic Catchment area follow-up study. Arch Gen Psychiatry (2000) 1.29
Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity. Nucl Med Biol (1998) 1.24
Dual-[11C]tracer single-acquisition positron emission tomography studies. J Cereb Blood Flow Metab (2001) 1.20
Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology (2003) 1.18
Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol. J Cereb Blood Flow Metab (1987) 1.16
Imaging the vesicular monoamine transporter. Adv Neurol (2001) 1.15
Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol (1993) 1.14
Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. J Cereb Blood Flow Metab (1997) 1.13
Spectral analysis of systemic arterial pressure and heart rate signals as a prognostic tool for the prediction of patient outcome in the intensive care unit. Crit Care Med (1997) 1.13
Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. J Cereb Blood Flow Metab (1999) 1.11
NCA 16 alpha-[18F]fluoroestradiol-17 beta: the effect of reaction vessel on fluorine-18 resolubilization, product yield, and effective specific activity. Int J Rad Appl Instrum A (1986) 1.10
Preparation of four fluorine- 18-labeled estrogens and their selective uptakes in target tissues of immature rats. J Nucl Med (1984) 1.08
Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biol Psychiatry (2001) 1.08
In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter. J Med Chem (1996) 1.05
Diminished vasomotor component of systemic arterial pressure signals and baroreflex in brain death. Am J Physiol (1997) 1.04
Decreased striatal monoaminergic terminals in Huntington disease. Neurology (2000) 1.03
Fluorine-18 labeling of proteins. J Nucl Med (1987) 1.00
[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse (1998) 0.98
Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. J Cereb Blood Flow Metab (1996) 0.98
PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol (1989) 0.97
Absolute configuration of (+)-alpha-dihydrotetrabenazine, an active metabolite of tetrabenazine. Chirality (1997) 0.97
High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates. Am J Psychiatry (2000) 0.96
Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences. Nucl Med Biol (2010) 0.96
[11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives. J Cereb Blood Flow Metab (1994) 0.95
Characterization of the uptake of 16 alpha-([18F]fluoro)-17 beta-estradiol in DMBA-induced mammary tumors. Int J Rad Appl Instrum B (1987) 0.94
Large pelvic accessory spleen mimicking an adnexal malignancy in a teenage girl. J Formos Med Assoc (2001) 0.94
Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J (1993) 0.93
[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity. Neuroscience (1995) 0.93
Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Int J Rad Appl Instrum B (1990) 0.92
Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study. Neuropsychopharmacology (2000) 0.91
Functional analysis of the 14 kDa protein of insertion sequence 2. J Mol Biol (1994) 0.89
In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brain. Life Sci (1992) 0.89
Detection of an IS2-encoded 46-kilodalton protein capable of binding terminal repeats of IS2. J Bacteriol (1996) 0.87
Embolic chondrosarcoma: an unusual cause of pulmonary embolism. Am Heart J (1993) 0.86
Use of three-dimensional ultrasound scan to assess the clinical importance of midurethral placement of the tension-free vaginal tape (TVT) for treatment of incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.86
High yield synthesis of high specific activity R-(-)-[11C]epinephrine for routine PET studies in humans. Nucl Med Biol (1993) 0.85
In vivo imaging of the brain vesicular monoamine transporter. J Nucl Med (1995) 0.85
Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter. Nucl Med Biol (1994) 0.85
Synthesis and regional mouse brain distribution of [11C]nisoxetine, a norepinephrine uptake inhibitor. Int J Rad Appl Instrum B (1989) 0.85
Synthesis of a [11C]methoxy derivative of alpha-dihydrotetrabenazine: a radioligand for studying the vesicular monoamine transporter. Appl Radiat Isot (1993) 0.84
Role of transoesophageal echocardiography in evaluation of cardiogenic embolism. Br Heart J (1991) 0.84
Central attenuation of baroreflex by angiotensin II in normotensive and spontaneously hypertensive rats. Am J Hypertens (1988) 0.83
Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology (1999) 0.82
Central attenuation of aortic baroreceptor reflex in prehypertensive DOCA-salt-loaded rats. Hypertension (1988) 0.82
Synthesis of carbon-11- and fluorine-18-labeled 1-methyl-4-piperidyl-4'-fluorobenzoate and their biodistribution in mice. Nucl Med Biol (1996) 0.82
Research and clinical potential of receptor based radiopharmaceuticals. J Nucl Med (1985) 0.82
Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue. Int J Rad Appl Instrum A (1986) 0.81
Direct simultaneous production of [15O]water and [13N]ammonia or [18F]fluoride ion by 26 MeV proton irradiation of a double chamber water target. Int J Rad Appl Instrum A (1990) 0.81
Acute effects of captopril on the baroreflex of normotensive and spontaneously hypertensive rats. Jpn Heart J (1986) 0.81
Robotic production of 2-deoxy-2-[18F]fluoro-D-glucose: a routine method of synthesis using tetrabutylammonium [18F]fluoride. Int J Rad Appl Instrum A (1988) 0.81
Conformational analysis of nonsteroidal estrogens: The effect of conformer populations on the binding affinity of meso- and dl-hexestrol to the estrogen receptor. Mol Pharmacol (1981) 0.81
Application of robotics to radiopharmaceutical preparation: controlled synthesis of fluorine-18 16 alpha-fluoroestradiol-17 beta. J Nucl Med (1986) 0.81
Control of a hospital-wide vancomycin-resistant Enterococci outbreak. Am J Infect Control (2008) 0.81
Cost-effective screening for urinary tract infections in urogynaecological patients. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.81
Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol (1991) 0.80
Radiopharmaceuticals labeled with short-lived positron-emitting radionuclides. Radioisotopes (1985) 0.80
Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nucl Med Biol (1995) 0.80
Antibody fragments labeled with fluorine-18 and gallium-68: in vivo comparison with indium-111 and iodine-125-labeled fragments. Int J Rad Appl Instrum B (1991) 0.80
Synthesis of (2-[11C]methoxy)rotenone, a marker of mitochondrial complex I activity. Nucl Med Biol (1995) 0.80
Epileptic discharges triggered by blinking and eye closure. Electroencephalogr Clin Neurophysiol (1976) 0.80
Managing ventricular ectopics: are ventricular ectopic beats just an annoyance? Singapore Med J (2011) 0.80
Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome. Neurology (2009) 0.80
Pulse reflection sites and effective length of the arterial system. Am J Physiol (1989) 0.80
Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Ann Neurol (1996) 0.79
Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor. Life Sci (1983) 0.79
Influence of sanitary conditions on the field performance of chlorpyrifos-based baits against American cockroaches, Periplaneta americana (L.) (Dictyoptera: Blattidae). J Vector Ecol (2000) 0.79
Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6',7'-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity. Nucl Med Biol (1995) 0.79
An improved [18O]water target for [18F]fluoride production. Int J Appl Radiat Isot (1985) 0.79
Centrally induced vasodepressor and sympathetic nerve responses to taurine. Jpn Circ J (1985) 0.78
Detection of sulfuric acid aerosols by ultraviolet scattering. Environ Sci Technol (1985) 0.78
Cardiovascular and sympathetic responses to ouabain injected into the hypothalamus in rats. Cardiovasc Res (1986) 0.78
Elimination of subterranean termite (Isoptera: Rhinotermitidae) colonies using a refined cellulose bait matrix containing noviflumuron when monitored and replenished quarterly. J Econ Entomol (2012) 0.78
Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET. Synapse (2001) 0.78
Strategies for in vivo measurement of receptor binding using positron emission tomography. J Cereb Blood Flow Metab (1986) 0.78
Synthesis, rodent biodistribution, dosimetry, metabolism, and monkey images of carbon-11-labeled (+)-2 alpha-tropanyl benzilate: a central muscarinic receptor imaging agent. J Nucl Med (1992) 0.77
Synthesis, (18)F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors. J Med Chem (2000) 0.77
Synthesis and in vivo evaluation of (E)-N-[(11)C]Methyl-4- (3-pyridinyl)-3-butene-1-amine ([(11)C]metanicotine) as a nicotinic receptor radioligand. Nucl Med Biol (2000) 0.77
Fluorine for hydroxy substitution in biogenic amines: asymmetric synthesis and biological evaluation of fluorine-18-labeled beta-fluorophenylalkylamines as model systems. J Med Chem (1995) 0.77
Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity. J Cereb Blood Flow Metab (2001) 0.77
Synthesis and evaluation of 6-[11C]methoxy-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-1,2- benzisoxazole as an in vivo radioligand for acetylcholinesterase. Nucl Med Biol (1999) 0.77
Automated production of several positron-emitting radiopharmaceuticals using a single laboratory robot. Int J Rad Appl Instrum A (1988) 0.77
Central attenuation of baroreflex precedes the development of hypertension in DOCA-salt-treated rats. Am J Hypertens (1988) 0.77
Non-steady-state measurement of in vivo receptor binding with positron emission tomography: "dose-response" analysis. J Neurosci (1989) 0.77
In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine. Synapse (1993) 0.77
Positive culture of the Janeway lesion in acute bacterial endocarditis. Taiwan Yi Xue Hui Za Zhi (1980) 0.77
Synthesis of [11C]tetrabenazine, a vesicular monoamine uptake inhibitor, for PET imaging studies. Appl Radiat Isot (1993) 0.77